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Ovarian cancer is the second most common gynaecological cancer
and is the leading cause of death from all gynaecological malig-
nancies. Over 90% of ovarian cancers are believed to result from
the malignant transformation of the ovarian surface epithelium.
Although the cause of epithelial ovarian carcinoma remains
unknown, it has been proposed that the repeated requirement for
growth activity in the surface epithelium without long periods of
rest somehow contributes to the process of malignant transforma-
tion (Fathalla, 1971). The poor prognosis for ovarian epithelial
malignancies is most likely related to the extensive dissemination
of tumour cells beyond the confines of the ovary at the time of
initial diagnosis (American Cancer Society, 1984). After 20 years
of intensive research there are still significant gaps in our knowl-
edge concerning ovarian cancer aetiology, development and
treatment.
One of the hallmarks of the tumour microenvironment is
regional hypoxia occurring because of insufficiencies in the vascu-
lature of the growing neoplasm (Moulder and Rockwell, 1987). In
accordance with the need by the cell to decrease energy usage
under low oxygen conditions, hypoxia induces cell cycle arrest in
many cell types (Heacock and Sutherland, 1990; Amellem and
Peterson, 1991; Graeber et al, 1994). We and others (Amellem and
Peterson, 1991; Graeber et al, 1994; Krtolica and Ludlow, 1996)
have shown that hypoxia induces cells to arrest preferentially in
the G1 phase or at the G1/S transition. Results from our laboratory
(Ludlow et al, 1993b; Krtolica and Ludlow, 1996) as well as others
(Amellem et al, 1996) demonstrate that concomitant with this
arrest is an accumulation of the hypophosphorylated, growth
suppressive form of the retinoblastoma protein, pRB. The pRB
protein regulates the cell’s decision during G1 to start another
round of cell division. Graeber et al (1994) have shown that
despite the accumulation of another tumour suppressor gene
product, p53, in at least some cell types during hypoxia, p53 does
not contribute to the observed G1 arrest. Taken together, these
observations are consistent with the hypothesis that G1 arrest in
hypoxia may be regulated through activation of the growth
suppressive function of pRB.
We have also previously shown that while hypoxic ovarian
carcinoma cells undergo reversible G1 cell cycle arrest, they still
retain their invasive capability (Krtolica and Ludlow, 1996). It has
also been well-established by others that cells under hypoxia often
demonstrate resistance to both radiation and chemical therapies
designed to halt their growth and proliferation (Wilson et al, 1989;
Sutherland, 1990; Hall, 1994). Therefore, it is tempting to specu-
late that in ovarian malignancies resistant hypoxic cells play a role
in maintaining a critical threshold of neoplastic cells capable of
repopulating the patient. Hence, identifying the critical biochem-
ical components of this hypoxia-induced growth suppression
mechanism will most certainly contribute towards our under-
standing in the fields of cell cycle control, hypoxia and potentially
in experimental therapeutics. Towards this goal, we have
continued to study the proliferation properties of both aerobic and
hypoxic human ovarian carcinoma cells at the molecular level.
The purpose of the study presented here is to assess the integrity
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proteins. Since hypoxia reversibly growth arrests SKA cells
during the G1 phase of the cell cycle (Krtolica and Ludlow, 1996),
we concentrated our investigative efforts on the proteins and their
complexes which are known to regulate progression from G1 into
S phase: cyclins D and E, the cyclin-dependent kinases (cdk) 4 and
2, the cdk inhibitors (cdki) p18 and p27, and the negative growth
regulatory protein pRB. With this information, we propose a
model to explain the effects of hypoxia on ovarian cancer cell
proliferation.
MATERIALS AND METHODS
Cell growth conditions
SKA is a continuous line of ovarian carcinoma cells derived from
patient isolates (Rofstad and Sutherland, 1988). SV80 is a trans-
formed human diploid fibroblast cell line which stably expresses
SV40 T-antigen (Todaro et al, 1966). These cells were maintained
in Dulbecco’s modified Eagle’s medium (DMEM; Gibco),
containing 10% fetal bovine serum at 37°C in a humidified, 5%
carbon dioxide-containing atmosphere.
Flow cytometry and DNA histogram analysis
Aerobic and hypoxic cells were harvested by trypsinization and
low speed centrifugation. The resulting cell pellet was then fixed
in ice-cold 70% ethanol and stored at 4°C until flow cytometric
analysis. Fixed cells (at least 5 ´ 105 cells) were then centrifuged
(55 g, 10 min), resuspended in 1 ml of phosphate-buffered saline
containing 1 mg ml–1 RNAase and incubated at room temperature
for 30 min. Propidium iodide was added to a final concentration of
10 mg ml–1, and flow cytometry was performed on a Profile 1 flow
cytometer (Coulter Counter, Coulter Electronics, Inc., Miami, FL,
USA). DNA histogram analysis was performed using the
MultiCycle AV DNA software package (Phoenix Flow Systems,
Inc., San Diego, CA, USA).
Cell elutriation
Approximately 108 cells were loaded into the separation chamber
at a flow rate of 36 ml per min and a rotor speed of 3250 rpm
(Beckman J6M centrifuge, JE-6 rotor, Beckman). Samples were
collected at a flow rate of 48 ml per min. After collecting the run-
off samples, rotor speed was decreased incrementally and 40-ml
samples collected at each rotor speed. A total of 28 fractions were
collected. The cells contained in these fractions were subsequently
counted and sized using a Coulter counter (Model ZM, Coulter
Electronics, Inc., Miami, FL, USA) and fractions containing popu-
lation of cells in the same phase of the cell cycle (same size) were
pooled. Cell cycle distribution was confirmed by flow cytometric
DNA analysis.
T-antigen binding and coprecipitation
SKA cells were starved for 30 min in methionine-free medium,
labelled with 0.5 mCi ml–1 of [35S]Met/Cys for 3 h, and lysed in
EBC buffer (50 mM Tris–HCl, pH 8.0, 120 mM sodium chloride
(NaCl), 0.5% Nonidet P-40) containing 10 mg ml–1 of the pro-
tease inhibitors aprotinin, leupeptin and phenylmethylsulphonyl
fluoride (PMSF). T-antigen containing SV80 cell lysate was then
mixed with [35S]-labelled SKA lysate at a ratio 1:3 and incubated
for 15 min at 4°C prior to immunoprecipitation with T-antigen
specific monoclonal antibody (PAB 419; Ludlow et al, 1989).
Immunoprecipitates were separated on 7.5% acrylamide gels and
visualized by autoradiography.
Establishing hypoxic cultures
Hypoxic conditions were established by placing cell cultures in
sealed chambers maintained at 37°C followed by repeated
exchange with 95% N2:5% carbon dioxide over a 2-h period.
Oxygen levels were measured in the conditioned medium at the
end of each experiment using an oxygen microelectrode
(Microelectrodes, Inc., Bedford, NH, USA) and were consistently
found to range between 0.5 and 1.5% oxygen, which calculates to
3.8–11.4 mmHg. For comparison, atmospheric oxygen (aerobic
conditions) equals 160 mmHg, the partial pressure of oxygen in
venous blood is 30–38 mmHg (Siggaard-Anderson et al, 1990),
while oxygen levels in tumours and spheroids are 10 mmHg
(1.3%) or lower (Sutherland, 1988). From our previous work
(Ludlow et al, 1993b; Krtolica and Ludlow, 1996; Krtolica et al,
1998), kinetic data on the time course of hypoxia indicated that by
12–18 h the cells had reached maximum growth arrest. The
observed cellular effects of hypoxia were not due to depletion of
glucose; measurement of glucose levels in conditioned medium
from aerobic and hypoxic cell cultures revealed that under all
conditions glucose remained above 80% of the amount present in
the fresh medium (Sigma Diagnostics Glucose, Procedure No.
510, Sigma, St Louis, MO, USA). There was no induction of cell
death under hypoxic conditions as determined by trypan blue
exclusion.
SDS-PAGE and Western blotting
All cells were lysed for 15 min at 4°C in EBC buffer (50 mM
Tris–HCl, pH 8.0, 120 mM NaCl, 0.5% Nonidet P-40) containing
10 mg ml–1 of the protease inhibitors aprotinin, leupeptin and
PMSF. The lysates were cleared by centrifugation at 14 000 g for
10 min. Electrophoresis was performed in 7.5%, 8%, 10% or 12%
sodium dodecyl sulphate (SDS)-polyacrylamide gels (Laemmli,
1970) using 100 mg of total cell protein for each sample lane
(Bradford, 1976). After electrophoresis, the proteins were trans-
ferred to nitrocellulose paper in buffer containing 25 mM
Tris–HCl, 192 mM glycine, 20% v/v methanol, and 0.01% SDS
(pH 8.5) (Towbin et al, 1979). Residual protein binding sites on
the nitrocellulose were blocked by incubation for 30 min in TBST
(25 mM Tris–HCl, pH 8.0, 150 mM NaCl, 0.5% Tween-20)
containing 4% non-fat dry milk. Next, the nitrocellulose was incu-
bated in TBST containing 2% non-fat dry milk containing either a
1:100 dilution of antibody to cyclin A (C160; Giordano et al,
1989, 1991), a 1:5 dilution of antibody to cyclin E (HE 12;
provided by Ed Harlow and Nick Dyson, Massachusetts General
Hospital, Boston, MA, USA), a 1 mg ml–1 concentration of cyclin
D1,2 antibody (06-137; Upstate Biotechnology, Inc. (UBI), Lake
Placid, NY, USA), 1 mg ml–1 of anti-cdk2 (rabbit polyclonal,
06–505; UBI), 1 mg ml–1 anti-cdk4 (SC-260; Santa Cruz
Biotechnology, Inc., Santa Cruz, CA, USA), 0.125 mg ml–1 of anti-
p27 (cat. No. K25020; Transduction Laboratories, Inc., Lexington,
KY, USA), or 1 mg ml–1 of anti-p18 (cat. No. 06-555; UBI)
Following three washes of 10 min each with TBST, the nitrocellu-
lose was probed with horseradish peroxidase-conjugated anti-IgG
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nescence detection (Pierce, Rockford, IL, USA) according to the
manufacturer’s instructions.
Preparation of [32P]pRB substrate and pRB-directed
phosphatase activity assays
To assay pRB-directed phosphatase activity, [32P]pRB substrate
was prepared by immunoprecipitation with monoclonal antibody
to pRB, PMG3-245 (PharMingen, San Diego, CA, USA) from
[32P]-labelled SKA cells as described previously (Nelson et al,
1997a, 1997b). For enzyme assays, cells were plated at 8 ´ 105
cells per 100-mm plate 16–18 h prior to experiment. At the end of
the treatment, cells were washed three times with 20 mM imida-
zole, pH 7.0, 150 mM NaCl and lysed by sonication in the same
buffer supplemented with 14 mM 2-mercaptoethanol and the
following protease inhibitors: 1 mM benzamidine, 50 mM TPCK,
50 mM TLCK, 50 mM leupeptin and 1 mM pepstatin. Lysates from
hypoxic or aerobic cells, normalized for protein content and
volume, were incubated with [32P]-labelled immunoprecipitated
pRB for 40 min at 30°C (assay samples) or mixed immediately
with SDS polyacrylamide gel electrophoresis (SDS-PAGE)
sample buffer (control samples). Phosphatase reactions were
terminated by the addition of SDS-PAGE sample buffer and
boiling. Proteins were separated on 8% SDS-polyacrylamide gels.
Gels were fixed, dried and activity was measured by assessing
incorporation of pRB radiolabel relative to controls and quantified
with a phosphorimager and ImageQuant Software (Molecular
Dynamics, Sunnyvale, CA, USA). Activity is measured as the
percent decrease in pRB band densities in experimental lanes
compared to control lanes.
Immunoprecipitation of cdk4 and cdk2 complexes
Cell lysates were prepared by scraping cells from the plate into
ice-cold kinase buffer (20 mM MOPS, pH 7.2, 25 mM b-glycerol
phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM
dithiothreitol (DTT) containing protease inhibitors (10 mg ml–1 of
aprotinin, leupeptin and PMSF) followed by sonication. Lysates
from hypoxic or aerobic cells containing 500 mg of total protein
were normalized to the same volume (approximate protein concen-
tration of 1 mg ml–1) and following a 1 h pre-clearing with
Staphylococcus protein A-Sepharose beads, immunoprecipitated
for 2 h with primary antibody at 4°C. Next, 50 ml of a 1:1 slurry of
protein A-beads in the kinase buffer was added and the precipitates
incubated for an additional hour. After three washes with kinase
buffer, precipitates were either immediately used for the kinase
assay or prepared for SDS-PAGE by the addition of 50 ml of
3  ´ SDS-PAGE sample buffer (6% SDS, 30% (v/v) glycerol, 0.3 M
DTT, 0.36 M Tris–HCl, pH 6.8) and then boiled. The following
rabbit polyclonal antibodies were used for these immunoprecipita-
tions: anti-cdk2 (06-505; UBI), anti-cdk4 (Sc-260; Santa Cruz
Biotechnology).
cdk2 kinase assays
Cell lysates were prepared and cdk2 immunoprecipitated as
described above. Assays were performed according to manu-
facturer’s instructions (Cyclin-dependent Kinase Assay Kit, 
17-137; UBI) in the presence of the following kinase inhibitors:
protein kinase C and protein kinase A inhibitor peptides and the
calmodulin-dependent kinase inhibitor compound R24570.
Reactions were terminated by cooling the mixtures in an ice water
bath. The sample was then mixed with SDS-PAGE sample buffer,
boiled and proteins separated on 12% SDS-polyacrylamide gels.
Gels were fixed, dried and activity was measured by assessing
incorporation of radiolabel into histone H1 relative to controls and
quantified using a phosphorimager with ImageQuant Software
(Molecular Dynamics, Sunnyvale, CA, USA).
pRB substrate preparation and cdk4 kinase assays
Full-length pRB fused to glutathione-S-transferase (GST-
pRB(1–928)) was expressed and purified from Escherichia coli strain
BL21pLys using glutathione-Sepharose beads as described
recently (Zarkowska and Mittnacht, 1997). GST-pRB(1–928) was
then eluted from the beads using excess glutathione, and estimates
of the amount of eluted GST-pRB(1–928) were made by comparing
silver-stained band intensities with those of known quantities of
bovine serum albumin. Approximately 2 mg of GST-pRB(1–928) was
then mixed with cdk4 immunoprecipitates from aerobic and
hypoxic-treated cells in kinase buffer (20 mM MOPS, pH 7.2,
25 mM b-glycerol phosphate, 5 mM EGTA, 1 mM sodium ortho-
vanadate, 1 mM DTT) containing protease inhibitors (10 mg ml–1 of
aprotinin, leupeptin and PMSF). Following the addition of 1 mCi
[32P]-ATP and incubation at 30°C for 30 min, the reactions were
terminated by adding SDS-sample buffer and boiling. Negative
control reactions using pre-immune rabbit serum and purified
mouse IgG immunoprecipitations revealed undetectable levels of
substrate phosphorylation.
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Figure 1 T-antigen coprecipitation of pRB from SKA cells. [35S]-labelled
SKA cell lysate was mixed with the non-labelled SV40 T-antigen-containing
SV80 cell lysate and immunoprecipitated with T-antigen-specific antibody
PAB 419. Samples were analysed using SDS-PAGE and autoradiography.
Lanes: 1 – T-antigen immunoprecipitation of radiolabelled SKA cell lysate
mixed with T-antigen-containing SV80 cell lysate; 2-immunoprecipitation of
radiolabelled SKA cell lysate alone using T-antigen-specific antibody;
3-immunoprecipitation of radiolabelled SKA cell lysate using pRB-specific
antibodyRESULTS
pRB from the SKA ovarian carcinoma cell line appears
to be wild-type and functional
It has been shown (Horowitz et al, 1989; Ludlow et al, 1989;
Bookstein et al, 1990; Kaye et al, 1990) that hypophosphorylated
wild-type pRB, but not its mutated inactive forms, binds to SV40
T-antigen. The ability of pRB to act as a growth suppressor
directly correlates with its ability to bind T-antigen. Thus, the
ability of pRB from particular cells to bind to T-antigen is taken as
a positive indicator of its functionality and wild-type status. To test
if pRB in SKA cells can bind to T-antigen, extracts were prepared
from [35S]-labelled SKA cells and mixed in a 1:3 ratio with
extracts prepared from T-antigen containing SV80 cells. T-antigen
was then immunoprecipitated with specific antibody and the
immunoprecipitates separated by SDS-PAGE and analysed by
autoradiography for the presence of radiolabelled pRB. As shown
in Figure 1, T-antigen immunoprecipitates of these mixed lysates
contained radiolabelled pRB which coprecipitated with T-antigen.
This result, taken together with reverse transcription polymerase
chain reaction (RT-PCR) and single-strand conformation polymor-
phism (SSCP) analysis which failed to detect aberations in regions
of pRB most often found mutated in RB1 non-functional mutants
(Horowitz et al, 1989; Bookstein et al, 1990; Kaye et al, 1990)
further supports our view that SKA ovarian carcinoma cells
express wild-type, functional, pRB.
pRB-directed phosphatase activity increases in SKA
cells exposed to hypoxia
As reported earlier (Krtolica and Ludlow, 1996) and also illus-
trated here (Figure 2), flow cytometery of asynchronously
growing SKA cells reveals an arrest in G1 or at the G1-S border
during hypoxia, as evidenced by a reduction in the S and G2-M
peaks of the DNA histogram. Such hypoxia-induced cell cycle
arrest is coincident with hypophosphorylation of pRB. One
possible explanation for this observation is that the intracellular
phosphatase activity directed towards pRB may be increased.
Since we have previously identified the pRB-directed phosphatase
as belonging to the type I class of serine/threonine protein phos-
phatases (PP1) and developed an in vitro assay to measure such
activity (Ludlow et al, 1993a), we tested the hypothesis that PP1
activity towards pRB is increased in SKA cells during hypoxia. As
shown in Figure 3, our experiments revealed a 48% increase in
pRB-directed phosphatase activity in hypoxic cell lysate relative
to the aerobic control. These data support our view that hypoxia-
induced hypophosphorylation of pRB, which renders this protein
active with respect to growth suppression (Buchkovich et al, 1989;
Chen et al, 1989; DeCaprio et al, 1989; Bartek et al, 1996),
involves an increase in PP1-mediated pRB dephosphorylation.
While cyclin D1,2 and cdk4 complexes are present in
SKA cells during hypoxia, cdk4 activity towards pRB is
decreased
Cyclin D–cdk4 and cyclin D–cdk6 activities enable cells to
progress through the G1 phase of the cell cycle and are some of the
main targets of cell cycle regulation (Resnitzky and Reed, 1995;
reviewed by Sherr, 1994). Although there are three types of cyclin
D, designated D1, D2 and D3, all are not necessarily found within
the same cell type. Our decision to concentrate our efforts on
cyclin D1,2–cdk4 was based on our ability to unequivocably detect
these proteins by Western blotting and also measure specific
kinase activity. In addition, cyclin D1,2 regulation does not appear
to be disrupted in these SKA cells (see Figure 5B). As shown in
Figure 4A, in SKA cell lysates the overall level of cyclin D1,2
decreases during hypoxia. We did detect somewhat of an increase
in cyclin D1,2 at the 18-h hypoxic time point relative to the 12-h
and 24-h hypoxic time points. Although not rigorously addressed
here, this increase may represent a population of S and G2/M cells,
which when slowed by hypoxia, eventually reach G1 between 12
and 18 h of hypoxia and then arrest. However, this level was still
below that of the aerobic control. cdk4 levels also decrease during
hypoxia, suggesting that the expression of these two proteins is
down-regulated during hypoxia-induced growth arrest of these
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Figure 2 DNA histogram analysis of aerobic and hypoxic SKA ovarian
carcinoma cells. Cell cultures were prepared as aerobic (left panel) or 18-h
hypoxic (right panel). Cell cycle distribution was determined by DNA
histogram analysis, as described in Materials and Methods. Peaks represent
populations of cells in G0/G1, S, and G2/M (peaks 1, 2 and 3 respectively)
Figure 3 Percent increase in pRB-directed phosphatase activity in hypoxia
relative to aerobic control. Cells were subjected to 18 h of hypoxia (18 h) or
maintained under aerobic conditions (A) and after lysis subjected to
phosphatase assay as described in Materials and Methods. The data are
presented as the average increase in pRB-specific phosphatase activity
relative to aerobic controls. Error bars represent standard error of the mean
for two samples performed in duplicateovarian cancer cells. p18, representative of the INK family of cdk
inhibitors (p15, p16, p19) which specifically inhibit cyclin D–cdk4
and cyclin D–cdk6 complexes (Guan et al, 1994), also decreases
over the time course of hypoxia, albeit less dramatically than
cyclin D1,2 and cdk4. Experiments using antibody specific for other
INK family members yielded inconclusive results, and thus we
were unable to accurately determine their abundance in these cells.
Immunoprecipitation studies using cdk4-specific antibody, in
which comparable amounts of cdk4 were immunocomplexed
(Figure 4B) reveal comparable amounts of cyclin D coprecipi-
tating with cdk4 during both aerobic and hypoxic conditions
(Figure 4C). Using cdk4 immunoprecipitates, activity assays
towards pRB were also performed. Kinase activity towards pRB is
reduced approximately 30% in cdk4 immunoprecipitates from
hypoxic cells (Figure 4D). Unfortunately, we were not able to
definitively determine the presence of p18 or other cdk inhibitors
in these immunoprecipitates. Nonetheless, we conclude from these
data that cyclin D1,2 from the SKA ovarian carcinoma cell line is
capable of forming an active complex with cdk4 during aerobic as
well as during hypoxic conditions, although the activity towards
pRB is is decreased in hypoxic cells. Taken together, these data
suggest that G1 progression during hypoxia is not inhibited by the
absence of cyclin D1,2–cdk4 complexes, but by the combined effect
of a lowering in abundance of the individual components of this
complex and a reduction in the catalytic activity of this complex,
perhaps resulting from increased binding by one or more types of
cdk inhibitors to the cyclin D1,2–cdk4 complex during hypoxia.
Cyclin D1,2, cyclin E, cyclin A and p27 protein during
SKA cell cycle follow the predicted pattern of
expression
Cyclin D1,2 can be found in varying concentrations throughout the
cell cycle, although there is a slight increase in abundance during
middle to late G1. Cyclin E and cyclin A are cdk2-positive regula-
tory subunits whose amounts vary during the cell cycle and control
the availability of the active cdk2 complexes in the cell. Cyclin
E–cdk2 activity is necessary for G1 to S transition, while progres-
sion through S phase is enabled by cyclin A–cdk2 complexes. p27
is a cdk inhibitor which binds to cdk2 complexes and inhibits their
activity. p27 concentration also varies during the cell cycle. To
establish if these cell cycle regulatory elements are properly
controlled during normal SKA cell cycling, we subjected SKA
cells to centrifugal elutriation. Separated populations of the cells in
the various phases of the undisrupted cell cycle (Figure 5A) were
lysed and used for immunoblot analysis with cyclin D1,2 cyclin E,
cyclin A and p27 antibodies (Figure 5B)
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Figure 4 (A) Detection of cyclin D1,2, cdk4, and p18 from hypoxic SKA cells. Equal quantities (100 µg) of whole-cell lysates prepared from cells maintained
under aerobic conditions (A) and 12- (12 h), 18- (18 h) and 24- (24 h) hour hypoxic cells were separated on 12% SDS-gels and subjected to immunoblotting for
detection of cyclin D1,2 (Cyc D1,2), cdk4, and p18 (indicated to the left of each panel) as described in Materials and Methods. (B) Immunoprecipitation of cdk4
from aerobic and hypoxic cell lysates. Equal quantities (500 mg) of whole-cell lysates prepared from cells maintained under aerobic conditions (A) and 18-h
hypoxic conditions (18 h) were immunoprecipitated using equal quantities of anti-cdk4 (1 µg) and separated on a 12% SDS-gel. Western blots were probed for
cdk4, the position of which is indicated by arrows on the left and right of the panel. (C) Coprecipitation of cyclin D1,2–cdk4 complexes from hypoxic and aerobic
cell lysates using cdk4 antibody. Cells were maintained under aerobic conditions (A) or for 12- (12 h) or 18- (18 h) hours in hypoxia, lysed and subjected to
immunoprecipitation with cdk4 antibodies as described above and in Materials and Methods. Western blots were probed for cyclin D1,2, the position of which is
indicated by arrows on the left and right of the panel. (D) pRB-directed cdk4 kinase activity. GST-pRB(1–928) bound to glutathione-Sepharose beads was mixed
with cdk4 immunoprecipitates from the aerobic and hypoxic cell lysates for the kinase reaction. The proteins were separated on a 6% SDS-gel and
phosphorylated pRB visualized by autoradiography1880 A Krtolica et al
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Figure 5 Distribution of cyclin D, cyclin E, cyclin A and p27 during SKA cell cycle. SKA cells were subjected to centrifugal elutriation. Cells were separated into
early (E), mid (M) and late (L) G1, S and G2 populations (panel A), lysed, normalized for protein, and used for immunoblot analysis (panel B) with cyclin D1,2,
cyclin E, cyclin A and p27 antibodies (indicated to the left of each panel). C – asynchronous control.The immunoblot analyses indicate that cyclin D1,2 can be found
in varying concentrations throughout the cell cycle, with an
observable increase during middle to late G1. Cyclin E abundance
increases in mid G1 and reaches a peak around the G1/S transition.
This is followed by a decrease in mid S phase and its complete
disappearance by early G2. The pattern of cyclin E expression
during SKA cell cycle is in accordance with reported data which
indicate that cyclin E associates with cdk2 in late G1 and that
cyclin E associated cdk2 activity is necessary for the G1 to S tran-
sition (reviewed by Heichman and Roberts, 1994). Therefore, we
concluded that cyclin D1,2 and cyclin E regulation does not seem to
be disrupted in SKA cells.
Cyclin A complexes with, and regulates the activity of, two cdk
catalytic subunits. During late G1 and early S phase cyclin A
replaces cyclin E in the cdk2 complexes. It remains bound to cdk2
throughout the S phase and is necessary for S phase progression
and entry into G2. In the mid to late G2, cyclin A concentration
increases and it binds to cdk1. Together with cyclin B–cdk1 (often
referred to as ‘maturation factor’) activity, cyclin A–cdk1 activity
is necessary for the onset of mitosis. Our results indicate that
cyclin A abundance during the SKA cell cycle follows the
expected pattern of cyclin A expression: it starts to emerge during
the G1 to S transition, and increases steadily throughout S and G2
phases. Cyclin A reaches its peak in abundance at the G2 to M
transition. This suggests that cyclin A expression does not appear
to be altered in the SKA ovarian carcinoma cell line and follows
the same pattern as in non-transformed cells. Finally, centrifugal
elutriation in conjunction with immunoblot analysis also revealed
the expected pattern of p27 expression in SKA; p27 is most abun-
dant in the G1 phase.
Increased abundance of p27 and cyclin E–cdk2–p27
complexes during hypoxia
Since hypoxic SKA cells appear to be reversibly growth arrested
during G1 (Krtolica and Ludlow, 1996), we decided to further
focus our attention on the key cdk which regulates transition from
G1 into S at the G1/S boundary; namely cyclin E–cdk2 complex.
As shown in Figure 6, little change in cdk2 abundance is observed
during the time course of hypoxia, while there is a significant
increase in p27 and overall decrease in cyclin E abundance
compared to the aerobic control. Immunoprecipitation studies
using cdk2-specific antibodies, in which comparable amounts of
cdk2 can be immunocomplexed from aerobic and hypoxic cell
lysate (Figure 6B) reveal that more p27 can be found in cyclin
E–cdk2 complexes during hypoxia, especially at the 12 h time
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Figure 6 (A) Immunoblot analysis of cyclin E, cdk2 and p27 abundance in SKA cell lysates exposed to hypoxia. Equal quantities (100 mg) of whole-cell lysates
prepared from cells maintained under aerobic conditions (A), 12- (12 h) and 18- (18 h) hour hypoxic cells were separated on 12% SDS-gels and subjected to
immunoblotting for detection of cyclin E (Cyc E), cdk2, and p27 (indicated to the left of each panel) as described in Materials and Methods. (B) Immuno-
precipitation of cdk2 from aerobic and hypoxic cell lysates. Equal quantities (500 mg) of whole-cell lysates prepared from cells maintained under aerobic
conditions (A), 12- (12 H), 18- (18 H) and 24- (24 H) hour hypoxic conditions were immunoprecipitated using equal quantities of anti-cdk2 (1 mg) and separated
on a 12% SDS-gel. Western blots were probed for cdk2, the position of which is indicated by arrows on the left and right of the panel. Fifty micrograms of whole-
cell lysate (L) and precipitation by normal rabbit serum and protein A beads (C) served as the positive and negative controls respectively. (C) Coprecipitation of
cyclin E–p27 complexes from hypoxic and aerobic cell lysates using cdk2 antibody. Cells were maintained under aerobic conditions (A) or for 12- (12 h) or
18- (18 h) hours in hypoxia, lysed and subjected to immunoprecipitation with cdk2 antibodies as described above and in Materials and Methods. Western blots
were probed for cyclin E and p27 as indicated to the left of the panel. (D) Histone H1-directed cdk activity in immunoprecipitates. Immunoprecipitations with
cdk2 antibodies and kinase assays were performed as described above and in Materials and Methods. [32P]-labelled phosphorylated histone H1 was visualized
by autoradiography.point, than during aerobic conditions (Figure 6C). cdk2 activity
towards histone H1 is also reduced approximately 33% in hypoxic
cell lysates (Figure 6D), perhaps resulting from this increase in
p27 binding to cyclin E–cdk2 complexes.
DISCUSSION
We have previously shown that ovarian carcinoma cell lines
reversibly growth arrest during hypoxia in the G1 phase of the cell
cycle and that this arrest is concomitant with accumulation of pRB
in its hypophosphorylated state (Krtolica and Ludlow, 1996). In
this study we have assessed the functionality of some of the key
regulators of the cell cycle in SKA ovarian carcinoma cells and
continued our elucidation of the molecular mechanism involved in
hypoxia-induced arrest.
Using T-antigen binding, we have demonstrated that pRB is
functional in SKA cells. This is in accordance with our hypothesis
that activation of pRB may play an important role in hypoxia-
induced cell cycle arrest in the SKA cell line. This hypothesis was
further supported by the pRB-directed phosphatase assays which
revealed that during hypoxia SKA cells increase their pRB-
directed phosphatase activity, thus contributing towards main-
taining pRB in the growth suppressive, hypophosphorylated state.
In addition, immunoblotting detected a decrease in both cyclin
D1,2 and cdk4 proteins during hypoxia, which implies that the
abundance of cyclin D1,2–cdk4 complexes should also be reduced.
Since the limiting component for active cdk4 complexes is the
cyclin D subunit, one may also infer from these data that cdk4
directed kinase activity, for which pRB is the principle substrate, is
also decreased during hypoxia. Indeed, our in vitro assay did
detect such a reduction. Thus, synergy between increased pRB-
directed phosphatase activity and decreased pRB-directed kinase
activity may be the mechanism behind the observed hypoxia-
induced increase in hypophosphorylated pRB.
In a similar vein, the limiting components for active cdk2
complexes are cyclins E and A. Like cyclin D, both cyclin A
(Krtolica and Ludlow, 1996) and cyclin E levels are significantly
decreased during hypoxia. In addition, there is an increase in p27
abundance with the onset of hypoxia which results in a higher
association of p27 with cdk2 complexes. This suggests a model of
hypoxia-induced arrest in which cdk4 activity is lower due to
decreased cyclin D and cdk4 abundance, while cdk2 activity is
perhaps inhibited through increased binding of p27 and a decrease
in availability of the positive regulatory subunits, cyclin E and
cyclin A. Since cyclin E–cdk2 and cyclin A–cdk2 complexes are
also capable of phosphorylating pRB, down-regulation of their
activities during hypoxia is also in accordance with the observed
increase in hypophosphorylated pRB during hypoxia, and
provides further support for a possible synergistic mechanism
between pRB-directed phosphatase and kinase activities to main-
tain pRB in the hypophosphorylated growth suppressive form
upon hypoxic exposure of ovarian carcinoma cells.
These data, taken together with reported inhibition of pRB-
directed kinase activity resulting from decrease in G1 cyclin avail-
ability and increase in p27–cdk2 association in hypoxic CV-1P
cells (Krtolica et al, 1998), has led us to propose the following
mechanism of hypoxia-induced growth arrest for these ovarian
carcinoma cells. Hypoxia-induced cell cycle arrest prevents cells
from starting the cell division cycle, an energetically expensive
process, under conditions when energy is limiting. Upon cell
exposure to hypoxia, the abundance of cdk inhibitor p27 is
elevated and, as a consequence, more p27 is available to bind
cyclin–cdk2 complexes, resulting in the decrease in cdk2 kinase
activity. At the same time, there is a decrease in the cyclin D and
cdk4 amounts leading to a decrease in cdk4 activity. Simultaneous
with inhibition of the kinase activity is an increase in pRB-directed
phosphatase activity. The concerted action of cdk inhibition and
increased pRB dephosphorylation leads to the net accumulation of
pRB in its active, hypophosphorylated form. This results in G1
growth arrest through repression of early S phase gene transcrip-
tion and consequent inhibition of DNA synthesis.
There seems to be a strong similarity between the mechanisms
involved in hypoxia induced growth arrest in non-transformed
monkey kidney CV-1P cells (Ludlow et al, 1993b; Krtolica et al,
1998) and the SKA ovarian carcinoma cell line (Krtolica and
Ludlow, 1996). These similarities suggest that our proposed model
for hypoxia-induced growth arrest may represent one of the
common pathways utilized by multiple cell types in response to
hypoxia and does not seem to be connected to the cancer cell pheno-
type per se. However, we cannot at this time exclude the possibility
that this pathway is limited to immortalized cells, since all of the cell
types used thus far for our studies belong to this category.
In closing, the results of the experiments described above and
those of our previous reports (Ludlow et al, 1993b; Krtolica and
Ludlow, 1996; Krtolica et al, 1998) lead us to conclude that several
key cell cycle regulatory elements: pRB, cyclins D, E, and A, cdk
inhibitors p27 and p18, and cdk4 and 2 are present, functional, and
capable of forming the appropriate complexes with one another, in
the SKA ovarian carcinoma cell line. Our data also suggest that the
decrease in cyclin D and cdk4 abundance may modulate cdk4
activity during hypoxia, that increased p27 binding to cyclin
E–cdk2 complexes may inhibit cdk2 kinase activity, and together
with the observed increase in PP1 phosphatase activity contribute
towards maintaining pRB in its growth suppressive, hypophos-
phorylated state during hypoxia. The next challenge is to formally
test the proposed model by molecularly dissecting the significance
of each component in the model. In this regard, we have recently
reported on a bioreactive protein capable of overriding hypoxia-
induced cell cycle arrest of SKA cells (Krucher et al, 1998). When
overriding hypoxia-induced cell cycle arrest, we can observe
concomitant reversal of several key molecular characteristics
reported here in response to hypoxia (i.e. increase in pRB hyper-
phosphorylation, decrease in p27 abundance) further supporting
integral involvement of these proteins in the mechanism of
hypoxia-induced cell cycle arrest. Future reports will include these
findings.
ACKNOWLEDGEMENTS
This work was supported by Research Project Grant # 98-108
from the American Cancer Society, The Sally Edelman & Harry
Gardner Cancer Research Foundation, University of Rochester
Cancer Center Discovery Fund (awarded to JWL) and Cancer
Center Core Grant CA11198. NAK is supported by National
Institutes of Health Cancer Research Training Grant T32
CA09363.
REFERENCES
Amellem O and Pettersen EO (1991) Cell inactivation and cell cycle inhibition as
induced by extreme hypoxia: the possible role of cell cycle arrest as a
protection against hypoxia-induced lethal damage. Cell Prolif 24: 127–141
1882 A Krtolica et al
British Journal of Cancer (1999) 80(12), 1875–1883 © 1999 Cancer Research CampaignAmellem O, Stokke T, Sandvik JA and Pettersen EO (1996) The retinoblastoma
gene product is reversibly dephosphorylated and bound in the nucleus in S and
G2 phases during hypoxic stress. Exp Cell Res 227: 106–115
Bartek J, Bartkova J and Lukas J (1996) The retinoblastoma protein pathway and the
restriction point. Curr Opin Cell Biol 8: 805–814
Bookstein R, Shew JY, Chen PL, Scully P and Lee WH (1990) Suppression of
tumorigenicity of human prostate carcinoma cells by replacing a mutated RB
gene. Science 247: 712–715
Bradford MM (1976) A rapid and sensitive method for quantitation of microgram
quantities of protein utilizing the principle of protein-dye binding. Anal
Biochem 72: 248–254
Buchkovich K, Duffy LA and Harlow E (1989) The retinoblastoma protein is
phosphorylated during specific phases of the cell cycle. Cell 58: 1097–1105
American Cancer Society (1984) Cancer Facts and Figures. Am Cancer Society:
New York
Chen PL, Scully P, Shew JY, Wang JYJ and Lee WH (1989) Phosphorylation of the
retinoblastoma gene product is modulated during the cell cycle and cellular
differentiation. Cell 58: 1193–1198
DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H,
Huang CM and Livingston DM (1989) The product of the retinoblastoma
susceptibility gene has properties of a cell cycle regulatory element. Cell 58:
1085–1095
Fathalla MF (1971) Incessant ovulation: a factor in ovarian neoplasia? Lancet
2: 163
Giordano A, Whyte P, Harlow E, Franza Br Jr, Beach D and Draetta G (1989)
A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in
adenovirus-infected cells. Cell 58: 981–990
Giordano A, McCall C, Whyte P and Franza BR Jr (1991) Human cyclin A and the
retinoblastoma protein interact with similar but distinguishable sequences in the
adenovirus E1A gene product. Oncogene 6: 481–485
Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O’Keefe CL, Matera AG and
Xiong Y (1994) Growth suppression by p18, a p16INK4/MTS1- and
p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb
function. Genes & Develop 8: 2939–2952
Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ Jr and Giaccia AJ (1994)
Hypoxia induces accumulation of p53 protein, but activation of G1-phase
check point by low-oxygen conditions is independent of p53 status. Mol Cell
Biol 14: 6264–6277
Hall EJ (1994) The oxygen effect and reoxygenation. In: Radiobiology for the
Radiologist, 4th edition, pp. 133–152. JB Lippincott: Philadelphia
Heacock CS and Sutherland RM (1990) Enhanced synthesis of stress proteins
caused by hypoxia and relation to altered cell growth and metabolism.
Br J Cancer 62: 217–225
Heichman KA and Roberts JM (1994) Rules to replicate by. Cell 79: 557–562
Horowitz JM, Yandell DW, Park SH, Canning S, Whyte P, Buchkovich K, Harlow E,
Weinberg RA and Dryja TP (1989) Point mutational inactivation of the
retinoblastoma antioncogene. Science 243: 937–940
Kaye FJ, Kratzke RA, Gerster JL and Horowitz JM (1990) A single amino acid
substitution results in a retinoblastoma protein defective in phosphorylation and
oncoprotein binding. Proc Natl Acad Sci USA 87: 6922–6926
Krtolica A and Ludlow JW (1996) Hypoxia arrests ovarian carcinoma cell cycle
progression, but invasion is unaffected. Cancer Res 56: 1168–1173
Krtolica A, Krucher NA and Ludlow JW (1998) Hypoxia-induced pRB
hypophosphorylation results from downregulation of CDK and upregulation of
PP1 activities. Oncogene 17: 2295–2304
Krucher NA, Krtolica A, Lincoln J, Khan SA, Rodriguez-Rodriguez L and Ludlow
JW (1998) Mitogenic activity of steroidogenesis-inducing protein (SIP) during
hypoxic stress of human ovarian carcinoma cells. Cancer Letters 133: 205–214
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head
of bacteriophage T4. Nature 227: 680–685
Ludlow JW, DeCaprio JA, Huang CM, Lee WH, Paucha E and Livingston DM
(1989) SV40 large T antigen binds preferentially to an underphosphorylated
member of the retinoblastoma susceptibility gene product family. Cell 56: 57–65
Ludlow JW, Glendening CL, Livingston DM and DeCaprio JA (1993a) Specific
enzymatic dephosphorylation of the retinoblastoma protein. Mol Cell Biol 13:
367–372
Ludlow JW, Howell RL and Smith HC (1993b) Hypoxic stress induces reversible
hypophosphorylation of pRB and reduction in cyclin A abundance independent
of cell cycle progression. Oncogene 8: 331–339
Moulder JE and Rockwell S (1987) Tumor hypoxia: its impact on cancer therapy.
Cancer Metastasis Rev 5: 313–341
Nelson DA and Ludlow JW (1997a) Characterization of the mitotic phase
pRB-directed protein phosphatase activity. Oncogene 14: 2407–2415
Nelson DA, Krucher NA and Ludlow JW (1997b) High molecular weight protein
phosphatase type 1 dephosphorylates the retinoblastoma protein. J Biol Chem
272: 4528–4535
Resnitzky D and Reed SI (1995) Different roles for cyclin D1 and E in regulation of
the G1-to-S transition. Mol Cell Biol 15: 3463–3469
Rofstad EK and Sutherland RM (1988) Radiation sensitivity of human ovarian
carcinoma cell lines in vitro: effects of growth factors and hormones, basement
membrane, and intercellular contact. Int J Radiation Oncology Biol Phys 15:
921–929
Sherr CJ (1944) G1 phase progression: cycling on cue. Cell 79: 551–555
Siggaard-Anderson O, Gothgen IH, Wimberley PD and Fogh-Anderson N (1990)
The oxygen status of the arterial blood revised: relevant oxygen parameters for
monitoring the arterial oxygen availability. Scand J Clin Invest 203: 17–28
Sutherland RM (1988) Cell and environment interactions in tumor microregions: the
multicellular spheroid model. Science 240: 177–184
Sutherland RM (1990) Induction of stress proteins and drug resistance in hypoxia
and applications of magnetic resonance spectroscopy and
cryospectrophotometry for detecting hypoxia in tumors. In: Selective Activation
of Drugs by Redox Processes, Adams GE (eds), pp. 97–111. Plenum Press:
New York
Todaro GJ, Green H and Swift MR (1966) Susceptibility of human diploid fibroblast
strains to transformation by Sv40 virus. Science 153: 1252–1254
Towbin H, Staehelin T and Gordon J (1979) Electrophoretic transfer of proteins from
polyacrylamide gels to nitrocellulose sheet: procedure and some applications.
Proc Natl Acad Sci USA 76: 4350–4354
Wilson RE, Keng PC and Sutherland RM (1989) Drug resistance in Chinese hamster
ovary cells during recovery from severe hypoxia. J Natl Cancer Inst 81:
1235–1240
Zarkowska T and Mittnacht S (1997) Differential phosphorylation of the
retinoblastoma protein by G1/S cyclin-dependent kinases. J Biol Chem 19:
12738–12746
Analysis of cell cycle proteins during hypoxia 1883
British Journal of Cancer (1999) 80(12), 1875–1883 © 1999 Cancer Research Campaign